Cloud-based Drug Design and Development

Cloud Pharmaceuticals is a leader in the burgeoning field of Artificial Intelligence based drug discovery.  The company partners, designs, develops, and licenses novel drug compounds for a wide range of medical indications to the pharmaceutical, biotechnology and medical research markets.  

The company launched in 2011 with a technology license from Duke University, and has since expanded through early stage funding arrangements from Microsoft, the National Science Foundation, and the University of Florida via its Gatorade royalty fund, and has more recently established a long-term collaboration with Glaxosmithkline (“GSK”).